by Jordana Choucair | Nov 22, 2021 | Life Sciences
Pfizer Inc. and BioNTech SE said that their COVID-19 vaccine was 100 percent effective at preventing infections among adolescents ages 12 to 15 within four months of their second doses, and that the shot showed no safety concerns for at least six months afterward. The...
by Jordana Choucair | Nov 22, 2021 | Life Sciences
A group of 15 human rights organizations is pushing President Biden to ensure that an intellectual property waiver for COVID-19 vaccines is enacted at the World Trade Organization. In a letter, the group says that access to the shots remains limited in low-income...
by Jordana Choucair | Nov 19, 2021 | Life Sciences
The FDA authorized Moderna and Pfizer’s COVID-9 booster shots for all U.S. adults today. A panel of scientific advisers to the CDC will meet later today to consider the FDA’s decision. If the panel agrees, anyone 18 or older will be eligible to receive a booster six...
by Jordana Choucair | Nov 18, 2021 | Life Sciences
The CMS extended the deadline for drugmakers to comply with the Trump-era regulation requiring them to calculate the “best price” for drugs under Medicaid’s drug rebate program using discounts they offer patients. The new final rule will officially...
by Jordana Choucair | Nov 18, 2021 | Life Sciences
AstraZeneca released new clinical trial results showing that its antibody treatment is highly effective at preventing COVID-19 in people who may not respond well to vaccines. According to the trial, patients given a single injection of the treatment were 83 percent...
by Jordana Choucair | Nov 18, 2021 | Life Sciences
Moderna submitted a revised request for the FDA to authorize booster doses of its COVID-19 vaccine for all adults. The FDA could grant Moderna and Pfizer clearance as early as this week. If the CDC also signs off, every adult who was fully vaccinated with the...
Recent Comments